Diagonal Bio AB (DIABIO) — Financial Flexibility Index
Diagonal Bio AB (DIABIO) has a Financial Flexibility Index of -1.07x as of September 2025. Free cash flow of Skr-2.27 Million (operating CF Skr-2.27 Million minus capex Skr0.00) represents -1% of total liabilities (Skr2.13 Million). Check Diagonal Bio AB (DIABIO) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Diagonal Bio AB Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Diagonal Bio AB across 5 annual periods. For the full cash flow conversion analysis, see how efficiently does Diagonal Bio AB generate cash.
Annual Financial Flexibility Index for Diagonal Bio AB (2020–2024)
Year-by-year free cash flow to debt coverage for Diagonal Bio AB. Explore DIABIO cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.77x | Skr-12.10 Million | Skr-13.77 Million | Skr2.54 Million | ▼ -3412.7% |
| 2023 | -0.14x | Skr-985.00K | Skr-5.23 Million | Skr7.26 Million | ▲ +96.5% |
| 2022 | -3.90x | Skr-10.82 Million | Skr-15.77 Million | Skr2.78 Million | ▼ -255.5% |
| 2021 | -1.10x | Skr-2.35 Million | Skr-10.94 Million | Skr2.14 Million | ▼ -622.0% |
| 2020 | 0.21x | Skr226.67K | Skr226.67K | Skr1.08 Million | — |